Neurologic disease in injection drug users: Therapeutic issues

Journal of NeuroVirology

Volumn 6, Issue SUPPL. 1, 2000, Pages

  Royal III, Walter ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Antiretroviral therapy; Cocaine; Human immunodeficiency; Injection drug use; Methadone; Nervous system

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; COCAINE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; METHADONE; NELFINAVIR; NEVIRAPINE; RETRIVIR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

CONFERENCE PAPER; DISEASE COURSE; DROWSINESS; DRUG METABOLISM; FATIGUE; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSOMNIA; INTRAVENOUS DRUG ABUSE; MYALGIA; NEUROLOGIC DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SIDE EFFECT; SOMNOLENCE; VERTIGO;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS DEMENTIA COMPLEX; ANTI-HIV AGENTS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; HIV-1; HUMANS; NERVOUS SYSTEM DISEASES; SUBSTANCE ABUSE, INTRAVENOUS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034128627     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Andersen SN, Skellerud K (1999). Hypoxic/ischemic brain damage, especially pallidal lesions, in heroin addicts. Forensic Sci Int 102: 51-59.
2. Baldwin GC, Roth MD, Tashkin DP (1998). Acute and chronic effects of cocaine on the immune system and the possible link to AIDS. J Neuroimmunol 83: 133-138.
3. Bell JE, Brettle RP, Chiswick A, Simmonds P (1998). HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 121: 2043-2052.
4. Benet LZ, Kroetz DL, Sheiner LB (1996). Pharmacokinetics. The dynamics of drug absorption, distribution, and elimination. In: Goodman & Gilman's, The Pharmacological Basis of Therapeutics. Hardman JG, Limbird LE, Milinoff PB, Ruddon RW, and Goodman A, (eds.) McGraw-Hill: New York, pp. 11-17.
5. Bouwman FH, Skolasky RL, Hes D, Selnes OA, Glass JD, Nance-Sproson TE, Royal W, Dal Pan GJ, McArthur JC (1998). Bariable progression of HIV-associated dementia. Neurology 50: 1814-1820.
6. Brust JCM (1993). Neurological aspects of substance abuse. (Stoneham: Butterworth-Heinemann). Centers for Disease Control and Prevention (1999). HIV/ AIDS Surveillance Report 11: 12.
7. Decker CJ, Laitinen LM, Bridson GW, Raybuck SA, Tung RD, Chaturvedi PR (1998). Metabolism of amprenavir in liver microsomes: role of CYP3A4 inhibition for drug interactions. J Pharm Sci 87: 803-807.
8. Donahoe RM, Vlahov D (1998). Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J Neuroimmunol 83: 77-87.
9. Eisenstein TK, Hilburger ME (1998). Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations. J Neuroimmunol 83: 36-44.
10. Ell JJ, Uttley D, Silver JR (1981). Acute myelopathy in association with heroin addiction. J Neurol Neurosurg Psychiatry 44: 448-450.
11. Flexner C (1998). HIV-Protease Inhibitors. New Engl J Med 338: 1281-1292.
12. Fredericks RK, Lefkowitz DS, Challa VER, Troost BT (1991). Cerebral vasculitis associated with cocaine abuse. Stroke 22: 1437-1439.
13. Heelon MW, Meade LB (1999). Methadone withdrawal when starting an antiretroviral regimen including nevirapine. Pharmacotherapy 19: 471-472.
14. Hsu A, Granneman GR, Bertz RJ (1998). Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents. Clin Pharmacokinet 35: 275-291.
15. Iribarne C, Dreano Y, Bardou LG, Menez JF, Berthou F (1997a). Interaction of methadone with substrates of human hepatic cytochrome P450 3A4. Toxicology 117: 13-23.
16. Iribarne C, Picart D, Dreano Y, Bail JP, Berthou F (1997b). Involvement of cytochrome P450 3A4 in N-dealkylation of buprenorphine in human liver microsomes. Life Sci 60: 1953-1964.
17. Judice DJ, Leblanc HJ, et al (1978). Spinal cord vasculitis presenting as a spinal cord tumor in a heroin addict. J Neurosurg 48: 131
18. LeDuc BW, Sinclair PR, Shusterk L, Sinclair JF, Evans JE, Greenblatt DJ (1993). Norcocaine and n-hydroxynorcocaine formation in human liver microsomes: role of cytochrome P-450 3A4. Pharmacology 46: 294-300.
19. Levine SR, Brust JCM, Futrell N, Brass LM, Blake D, Fayad P, Schultz LR, Millikan CH, Ho K-L, Welch KMA (1991). A comparative study of the cerebrovascular complications of cocaine: alkaloidal versus hydrochloride - a review. Neurology 41: 1173-1177.
20. Lipton SA, Gendelman HE (1995). Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 332: 934-940.
21. Little KY, Zhang L, Frey KA, Dalack GW, Cassin BJ (1999). Striatal dopaminergic abnormalities in human cocaine users. Am J Psychiatry 156: 238-245.
22. Margolis MT, Newton TH (1971). Methamphetamine ("Speed") arteritis. Neurorad 2: 179-182.
23. McCance-Katz EF, Rainey PM, Jatlow P, Friedland G (1998). Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262). J Acquir Immune Defic Syndr Hum Retrovirol 18: 435-443.
24. McCann UD, Wong DF, Yokoi F, Billemange B, Dannals RG, Ricaurte GA (1998). Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35, 428. J Neurosci 18: 8417-8422.
25. Miller EN, Selnes OA, McArthur JC, Satz P, Becker JT, Cohen BA, Sheridan K, Machado AM, Van Gorp WG, Visscher B (1990). Neuropsychological performance in HV-1-infected homosexual men: the Multicenter AIDS Cohort Study. Neurology 40: 197-203.
26. Mirken B (1997). Danger: possibly fatal interactions between ritonavir and "ecstasy," some other psychoactive drugs. AIDS Treat News 265: 5.
27. Moody DE, Alburges ME, Parker RJ, Collins JM, Strong JM (1997). The involvement of cytochrome P450 34A in the H-demethylation of L-alpha-acetylmethadol (LAAM), norLAAM, and methadone. Drug Metab Dispos 25: 1347-1353.
28. Nair MPN, Schwartz SA, Polasani R, Hou J, Sweet A, Chadha KC (1997). Immunoregulatory effects of morphine on human lymphocytes. Clin Diag Immunol 4: 127-132.
29. Palm S, Mignat C, Kuhn K, Umbreit H, Barth J, Stuber F, Maier C (1996). Phytohemagglutinin-dependent T cell proliferation is not impaired by morphine. Methods Find Exp Clin Pharmacol 18: 159-165.
30. Petito CK, Navia BA, Cho ES, Jordan BD, George DC, Price RW (1985). Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med 312: 874-879.
31. Price RW, Brew BJ (1988). The AIDS dementia complex. J Infect Dis 158: 1079-1083.
32. Richter RW, Rosenberg RN (1968). Transverse myelitis associated with heroin addiction. JAMA 206: 1255-1258.
33. Royal III W, Updike M, Selnes OA, Proctor TV, Nance-Sproson L, Solomon L, Vlahov D, Cornblath DR, McArthur JC (1991). HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology 41: 1905-1910.
34. Sanchez E, Villar D, Tephly TR (1978). Structural requirements in the reaction of morphine uridine diphosphare glucuronyltransferase with opioid substances. Biochem J 169: 173-177.
35. Sawaya GR, Kaminski MJ (1990). Infarction of spinal cord after intranasal cocaine. South Med J 83: 601-602.
36. Selnes OA, McArthur JC, Royal III W, Updike ML, Nance-Sporson T, Concha M, Gordon B, Solomon L, Vlahov D (1992). HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology 42: 1924-1930.
37. Selnes OA, Galai N, McArthur JC, Cohn S, Royal III W, Esposito D, Vlahov D (1997). HIV infection and cognition in intravenous drug users: long-term follow-up. Neurology 48: 223-230.
38. Trapnell CB, Klecker RW, Jamis-Dow C, Collins JM (1998). Glucuronidation of 3′-azido-3′deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquine, fluconazole, methadone, and valproic acid. Antimicrob Agents Chemother 42: 1592-1596.
39. Veal GJ, Back DJ (1995). Metabolism of zidovudine. Gen Pharmacol 26: 1469-1475.
40. Watkins PB (1995). Gastrointestinal toxicology. In: Textbook of gastroenterology. Yamada T, Alpers DH, Powell DW, Owyang C, and Silverstein FE, (eds.) JB Lippincott Company: Philadelphia, pp. 599-605.